🔎 Trials Near Me

መነሻ › የክሮን በሽታ › New York

በNew York ለየክሮን በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች

ለየክሮን በሽታ የሚደረጉ 36 ጥናቶች በNew York ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በNew York ውስጥ ያሉ ከተሞች

Official study text (English)

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

  • New York Gastroenterology Associates ( Site 0253), New York
ተሳታዮችን በመፈለግ ላይደረጃ 3
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06651281

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • Northwell Health Physician Partners Center for Advanced IBD Care ( Site 5017), Great Neck
  • NYU Langone Health - Inflammatory Bowel Disease Center (IBD) ( Site 5078), New York
  • Weill Cornell Medical College, New-York Presbyterian Hospital ( Site 5079), New York
  • እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Westchester Putnam Gastroenterology PC, Carmel
  • Five Towns Gastroenterology, Cedarhurst
  • IMIDeology, Elmhurst
  • እና 5 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06581328

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Weill Cornell Medical College - Judith Jaffe Multiple Sclerosis Center, New York
  • Icahn School of Medicine at Mount Sinai, New York
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05923073

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  • Nyu Langone Long Island Clinical Research Associates - Lake Success /ID# 265566, Lake Success
  • Northwell Health-Lenox Hill Hospital /ID# 265527, New York
  • Care Access - Yonkers /ID# 266781, Yonkers
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06548542

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  • Westchester Putnam Gastroenterology, Carmel
  • New York Gastroenterology Associates, New York
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07499232

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

  • Westchester Putnam Gastroenterology, Carmel
  • Inflammatory Bowel Disease Center at NYU Langone, New York
  • Weill Cornell Medical College, New York
  • እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07196722

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

  • Icahn School of Medicine at Mount Sinai (ISMMS) - The Mount Sinai Hospital (MSH), New York
  • Rochester Clinical Research, Inc, Rochester
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06233461

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • New York Gastroenterology Associates, New York
  • Care Access - Yonkers, Yonkers
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06937099

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • NYU Langone Hospital - Long Island, Mineola
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT03816345

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • MedTraits NY-Site Number: 8400045, Maspeth
  • Manhattan Clinical Research, LLC-Site Number: 8400069, New York
  • NYU Langone Health-Site Number: 8400091, New York
  • እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • MedTraits NY-Site Number: 8400045, Maspeth
  • NYU Langone Health-Site Number: 8400091, New York
  • Weill Cornell Medicine - NewYork-Presbyterian Hospital-Site Number: 8400040, New York
  • እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07184944

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

  • Icahn School of Medicine at Mount Sinai /ID# 254880, New York
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT05995353

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Icahn School of Medicine at Mount Sinai, New York
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 19 · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT04844606

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

  • NYU Langone Health, New York
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06045754

Standardized Microbiota Transplant Therapy in Crohn's Disease

  • NYU Langone Health, New York
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 89 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06631586

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  • New York Gastroenterology Associates, New York
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦገስ 2026 · NCT07577843

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

  • Weill Cornell Medical College (WCMC) - Judith Jaffe Multiple Sclerosis Center (JJMSC), New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University Medical Center/New York Presbyterian, New York
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT05509777

Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease

  • Weill Cornell Medicine, New York
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT06274554

Behavioral Therapy for Crohn's Disease

  • Icahn School of Medicine at Mount Sinai, New York
  • New York Gastroenterology Associates, New York
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2026 · NCT06512597

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • Saratoga Schenectady Gastroenterology Associates, Burnt Hills
  • NYU Langone Health, New York
  • Cornell University, New York
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT05230173

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  • New York University, New York
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦገስ 2026 · NCT07237516

Low Dose IL-2 for the Treatment of Crohn's Disease

  • Mount Sinai, New York
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ12 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT04263831

Autologous Stem Cell Transplant for Crohn's Disease

  • Icahn School of Medicine at Mount Sinai, New York
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁላይ 2026 · NCT03219359

Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease

  • Icahn School of Medicine at Mount Sinai /ID# 262216, New York
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁን 2026 · NCT06332534

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • New York Presbyterian Hospital, New York
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT06405087

Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease

  • Icahn School of Medicine at Mount Sinai, New York
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ5 ጁን 2026 · NCT06976853

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

  • Cohen Children's Medical Center of NY, Lake Success
  • Columbia University Medical Center, New York
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ6 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ27 ሜይ 2026 · NCT05781152

A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

  • Columbia University Medical Center, New York-Presbyterian Hospital, New York
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ27 ሜይ 2026 · NCT06227910

Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis

  • Weill Cornell Medical College, New York
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ14 ሜይ 2026 · NCT03256240

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

  • The Steven and Alexandra Cohen Childrens Medical Center of New York - BRANY - PPDS, New Hyde Park
  • Stony Brook University Medical Center, Stony Brook
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ2 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT04779320

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, New York
  • Mirador Therapeutics Selected Site, Rochester
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ12 ማርች 2026 · NCT07113522

Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflammation

  • Icahn School of Medicine at Mount Sinai, New York
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጃንዩ 2026 · NCT06001450

Treatment of Moderate to Severe Refractory Crohn's Disease

  • Mount Sinai Health Systems, New York
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ10 ዲሴም 2025 · NCT06721962

Helmsley 3.0: Abbreviated MRE

  • NYU Langone, New York
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 10 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ኦክቶ 2025 · NCT06533228

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።